- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02761018
Using Technology to Share Fitness Goals and Results to Improve Diabetes Outcomes
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Male and female DoD beneficiaries ages 18 years or older who have been diagnosed with Type II diabetes, will be recruited at the Mike O'Callaghan Federal Medical Center (MOFMC).
Screening Visit:
- Obtain signed Informed Consent Document and HIPAA Authorization (research-driven).
- Record: Date of birth, phone number, age, gender, race, ethnicity, social security number, current email address, height (in inches), weight (in pounds), blood pressure, medications list including any over-the-counter and prescription weight loss medication (name, strength, dose) or supplements.
Subjects will have the following standard of care blood test drawn which include:
- Hemoglobin A1c via 1 venipuncture (5-10 mls, approximately 1-2 teaspoons of blood will be drawn)
Visit 1 (Day 1 within 1 week of Screening Visit):
- Record: Weight (in pounds), blood pressure, and any changes to their medications list.
- Subjects will complete the RAND 36 Item Health Survey.
- Subjects will complete the Intake Questionnaire.
- Subjects will be assigned their Fitness Tracker username and their username and password will be recorded by the Research Coordinator.
- Subjects will be given User Instructions based off of their randomization group.
- Subjects will be instructed to follow all research procedures and that failure to do so may result in the removal from the study and the return of the Fitness Tracker.
Subjects will be randomized by the research coordinator using a random-number generator into one of two groups (research-driven):
- Group 1: will use a fitness tracker but will not be able to see other participant's data.
Group 2: will use a fitness tracker and will be able to see other member's daily and weekly results.
- Both groups will receive the scripted feedback at set time intervals by the Research Coordinators.
Subjects will be provided a fitness tracker and instructed on how to use it.
- If subject is a DoD beneficiary, and finishes all study-related procedures at month 6, they will keep the fitness tracker. If a subject does not complete all study-related procedures, they will be asked to return the fitness tracker so the investigators can erase their data and re-issue to another study subject.
- If subject is active duty or a DoD employee, regardless of their study completion, they will be asked to complete Temporary Issue Receipt and bring back the fitness tracker at the end of the study.
Visit 2 (Month 3/90 days post Visit 1):
- Record: Weight (in pounds), blood pressure and any changes to their medications list.
- Subjects will complete the RAND 36 Item Health Survey.
- Subjects will complete the Follow up Questionnaire.
- Obtain information from their fitness tracker.
Subjects will have the following standard of care blood test drawn which include:
- Hemoglobin A1c via 1 venipuncture (5-10 mls, approximately 1-2 teaspoons of blood will be drawn)
Final Visit 3 (Month 6/90 days post Visit 2):
- Record: Weight (in pounds), blood pressure and any changes to their medications list.
- Subjects will complete the RAND 36 Item Health Survey and be asked some additional questions.
- Subjects will complete the Follow up Questionnaire.
- Obtain information from their fitness tracker.
Subjects will have the following standard of care blood test drawn which include:
- Hemoglobin A1c via 1 venipuncture (5-10 mls, approximately 1-2 teaspoons of blood will be drawn)
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Nevada
-
Nellis Air Force Base, Nevada, United States, 89191
- Mike O'Callaghan Federal Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
YOU MUST BE ABLE TO GET CARE AT NELLIS AFB (A MILITARY INSTALLATION) IN ORDER TO PARTICIPATE IN THIS STUDY.
Inclusion:
- Male and female DoD beneficiaries, age 18 years or older, who have been diagnosed with Type II Diabetes
- Ability to set up fitness tracking software on personal computer or cell phone
- Ability to learn and use personal activity monitor
Exclusion:
- Male and female DoD beneficiaries, under the age of 18 years
- Unwilling to share personal fitness results anonymously
- Inability to do 4 metabolic equivalents of exercise (walk 100feet, walk up flight of stairs etc).
- Inability to walk without the use of assistive devices (cane is OK)
- Medical problem which would make walking unsafe (recent surgery, uncontrolled heart condition, fall risk etc).
- No special populations (e.g., pregnant women, children, prisoners, detainees) will be recruited.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Fitness Tracker
will use a fitness tracker but will not be able to see other participant's data
|
will use a fitness tracker and will be able to see other member's daily and weekly results
|
Experimental: Fitness Tracker with Group Participation
will use a fitness tracker and will be able to see other member's daily and weekly results
|
will use a fitness tracker but will not be able to see other participant's data
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Reduction in hemoglobin a1c
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: David Carlsen, MD, Principal Investigator
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FWH20160062H
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type II Diabetes Mellitus
-
pico-tesla Magnetic Therapies, LLCCompletedType II Diabetes MellitusUnited States
-
Medical College of WisconsinMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
KeyBioscience AGEli Lilly and Company; Profil Institut für Stoffwechselforschung GmbH; Nordic...TerminatedType II Diabetes MellitusGermany
-
HealthInsightCenter for Technology and Aging; VoxivaUnknownType II Diabetes MellitusUnited States
-
University of PretoriaNestlè Nutrition Institute Africa; South African Sugar AssociationCompletedDiabetes Mellitus, Type II [Non-insulin Dependent Type] [NIDDM Type] UncontrolledSouth Africa
-
Microbio Co LtdCompleted
-
University of PrimorskaUniversity of Ljubljana School of Medicine, SloveniaCompletedDiabetes Mellitus Type II,Slovenia
-
Laboratorios Silanes S.A. de C.V.RecruitingDyslipidemia Associated With Type II Diabetes MellitusMexico
-
Assiut UniversityNot yet recruitingDyslipidemia Associated With Type II Diabetes Mellitus
Clinical Trials on Fitness Tracker
-
University Hospital TuebingenUnknownCancer | Fatigue | Physical ActivityGermany
-
Virginia Commonwealth UniversityCystic Fibrosis FoundationWithdrawn
-
University of LimerickUnknownCystic FibrosisIreland
-
Colorado State UniversityCompleted
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedOvarian CancerUnited States
-
Cedars-Sinai Medical CenterRecruitingNeoplasms | Cancer | Cancer, MetastaticUnited States
-
HagaZiekenhuisDelft University of TechnologyEnrolling by invitationAtrial Fibrillation | Heart Failure, SystolicNetherlands
-
University Hospital of North NorwayNorwegian University of Science and Technology; St. Olavs Hospital; Laval University and other collaboratorsCompletedPhysical Activity Promotion Among Inactive AdultsNorway
-
Wake Forest University Health SciencesWithdrawnStress | Burnout | Sleep Deprivation | Wellness
-
Coeus Health, LLCCompletedWeight Loss | Health BehaviorUnited States